Skip to main content
Clinical Trials/IRCT20091111002695N8
IRCT20091111002695N8RecruitingPhase 2

The effect of Azithromycin on airways remodeling in patients with severe refractory asthma

Islamic Azad University0 sites75 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
75

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Patients suffering from severe refractory asthma who could not be controlled by high dose corticosteroids and long acting beta2 agonists or by antileukotrienes with or without tiotropium.
  • FEV1 must be less than 80 percent.

Exclusion Criteria

  • Allergic bronchopulmonary aspergillosis
  • Drug allergy
  • Pregnancy or Breast milk feeding
  • Interstitial lung disease such as Vasculitis
  • Recent lung infection
  • Gastroesophageal reflux

Investigators

Similar Trials